Table 2.
Relative probabilities (RR, non-blinded vs blinded subtrial) of the willingness by woman and of the eligibility by doctor and the ultimate attendance by the woman's symptoms, EPHT Trial
| Symptom* | Willingness (95% CI) | Eligibility (95% CI) | Attendance (95% CI) |
|---|---|---|---|
| Lack of breath | |||
| No | 1.21 (1.13 to 1.31) | 1.06 (1.00 to 1.13) | 1.30 (1.17 to 1.42) |
| Yes | 1.11 (0.97 to 1.27) | 1.22 (1.08 to 1.38) | 1.36 (1.13 to 1.62) |
| Diarrhoea or constipation | |||
| No | 1.12 (1.04 to 1.21) | 1.06 (0.99 to 1.13) | 1.19 (1.07 to 1.32) |
| Yes | 1.32 (1.17 to 1.47) | 1.22 (1.07 to 1.21) | 1.55 (1.33 to 1.81) |
| Stomach pain | |||
| No | 1.17 (1.09 to 1.26) | 1.07 (1.00 to 1.14) | 1.25 (1.14 to 1.37) |
| Yes | 1.16 (0.99 to 1.37) | 1.28 (1.05 to 1.36) | 1.48 (1.17 to 1.88) |
| Swelling | |||
| No | 1.20 (1.12 to 1.30) | 1.07 (1.03 to 1.21) | 1.28 (1.17 to 1.42) |
| Yes | 1.04 (0.91 to 1.19) | 1.20 (1.05 to 1.36) | 1.24 (1.03 to 1.50) |
| Hot flushes | |||
| No | 1.17 (1.07 to 1.28) | 1.12 (1.03 to 1.21) | 1.31 (1.16 to 1.47) |
| Yes | 1.17 (81.08 to 1.27) | 1.06 (1.00 to 1.14) | 1.27 (1.12 to 1.38) |
| Sweating | |||
| No | 1.16 (1.06 to 1.28) | 1.09 (1.01 to 1.19) | 1.27 (1.13 to 1.44) |
| Yes | 1.18 (1.08 to 1.28) | 1.10 (1.02 to 1.17) | 1.29 (1.16 to 1.43) |
| Total (reference value) | 1.17 (1.11 to 1.24) | 1.10 (1.05 to 1.15) | 1.29 (1.20 to 1.38) |
*Those with the symptom unknown are excluded.
EPHT, Estonian Postmenopausal Hormone Therapy; RR, relative risk.